Global Lung Stent Market size was valued at USD 193.9 Million in 2023 and is expected to reach USD 354.6 Million by 2032, at a CAGR of 7.4% during the forecast period 2023 – 2032.

Lung Stent Market: Overview

A lung stent, also referred to as a tracheobronchial stent or airway stent, is a medical device that keeps the passageways in the lungs open. It is often utilized for managing airway blockages or constriction caused by illnesses such as lung cancer or tracheal stenosis.

In recent years, there have been numerous major trends in the worldwide lung stent market. One noticeable trend is the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), lung cancer, and pulmonary fibrosis, which is driving up demand for lung stents as a therapy.

Furthermore, advances in technology and materials have resulted in the creation of more effective and long-lasting stents, which improve the results for patients and reduce problems. Furthermore, there is a growing focus on minimally invasive techniques, including the use of lung stents, because they provide advantages such as shorter recovery periods and a decreased risk of problems when compared to standard surgical methods.

Furthermore, the aging population and the increase in smoking incidence in some areas have led to the enlargement of the lung stent market.

By type, the tracheobronchial stents segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. Tracheobronchial stents in the Lung Stent industry have seen developments in stent materials, less invasive delivery procedures, individualized stent designs, and the incorporation of imaging technology for specific insertion.

By material, the metal stents segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. Metal stents dominate the lung stent market due to their reliability, adaptability, and capacity to give ongoing assistance to airways afflicted by diseases such as lung cancer, making them a preferable therapeutic choice.

By end user, the hospitals segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. The lung stent market is driven by hospitals owing to the need for improved medical devices to treat respiratory problems, increasing interest in minimally invasive treatments, and a growing senior population suffering from lung-related diseases.

North America dominates the Lung Stent market due to variables that involve escalating respiratory illness incidence, sophisticated medical facilities, increased use of minimally invasive treatments, and high healthcare spending in the area.

Medtronic pioneered endoluminal lung ablation with the ILLUMISITE™ platform. Professor Calvin Ng and Dr. Rainbow Lau from Hong Kong accomplished the least invasive treatment on an individual with a lung lesion. The ILLUMISITE™ platform created a virtual trail through a patient’s lungs based on a CT image, similar to a GPS map used for navigation.

Report Scope

Feature of the Report Details
Market Size in 2023 USD 193.9 Million
Projected Market Size in 2032 USD 354.6 Million
Market Size in 2022 USD 191.5 Million
CAGR Growth Rate 7.4% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Type, Material, End User and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

CMI has comprehensively analyzed the Global Lung Stent market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict depth scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this Global Lung Stent industry.

The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

Global Lung Stent Market 2023–2032 (By Million)

List of the prominent players in the Lung Stent Market:

  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Becton Dickinson and Company
  • Medtronic plc
  • Teleflex Incorporated
  • Merit Medical Systems Inc.
  • Novatech SA
  • Benson Hood Laboratories Inc.
  • Micro-Tech (Nanjing) Co. Ltd.
  • Taewoong Medical Co. Ltd.
  • Stening SRL
  • EFER Endoscopy Srl
  • BVM Medical Limited
  • Boston Scientific Corporation
  • Hobbs Medical Inc.
  • S&G Biotech Inc.
  • Expandium S.A.
  • H&H Medical Corporation
  • Merit Endotek
  • Others

The Lung Stent Market is segmented as follows:

By Type

  • Tracheobronchial Stents
  • Esophageal Stents
  • Pulmonary Artery Stents
  • Lobar Bronchus Stents
  • Others

By Material

  • Metal Stents
  • Silicone Stents
  • Hybrid Stents
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics


  • Self-Expandable Stents
  • Non-Expandable Stents

By Patient

  • Adult
  • Pediatric

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America


  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America